Symbol:
Cdk2ap1
Name:
cyclin-dependent kinase 2 associated protein 1
RGD ID:
1308664
Description:
Predicted to enable DNA polymerase binding activity. Predicted to be involved in positive regulation of protein phosphorylation and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within face morphogenesis and in utero embryonic development. Predicted to be located in several cellular components, including chromatin; nucleoplasm; and perinuclear region of cytoplasm. Predicted to be part of NuRD complex. Predicted to be active in cytoplasm and nucleus. Orthologous to human CDK2AP1 (cyclin dependent kinase 2 associated protein 1); INTERACTS WITH 17alpha-ethynylestradiol; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
CDK2 (cyclin-dependent kinase 2)-associated protein 1; CDK2-associated protein 1; cyclin-dependent kinase 2-associated protein 1; LOC360804
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Related Pseudogenes:
Cdk2ap1-ps1
Cdk2ap1-ps2
Cdk2ap1-ps3
Cdk2ap1-ps4
Cdk2ap1-ps5
Cdk2ap1-ps6
Cdk2ap1-ps7
Cdk2ap1-ps8
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 37,910,718 - 37,919,446 (+) NCBI GRCr8 mRatBN7.2 12 32,249,752 - 32,258,483 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 32,249,747 - 32,258,479 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 33,429,132 - 33,437,872 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 34,040,461 - 34,049,199 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 33,092,339 - 33,101,075 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 37,668,369 - 37,677,067 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 37,668,369 - 37,677,063 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 39,538,931 - 39,539,222 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 12 39,545,402 - 39,549,786 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 33,365,372 - 33,374,597 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 33,228,844 - 33,237,985 (+) NCBI Celera 12 33,942,086 - 33,946,470 (+) NCBI Celera Cytogenetic Map 12 q15 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cdk2ap1 Rat 1,2-dimethylhydrazine increases expression ISO Cdk2ap1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of CDK2AP1 mRNA CTD PMID:22206623 Cdk2ap1 Rat 1,2-dimethylhydrazine multiple interactions ISO Cdk2ap1 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of CDK2AP1 mRNA] CTD PMID:22206623 Cdk2ap1 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CDK2AP1 mRNA CTD PMID:17108234 Cdk2ap1 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CDK2AP1 mRNA CTD PMID:32145629 Cdk2ap1 Rat 17beta-estradiol increases expression ISO Cdk2ap1 (Mus musculus) 6480464 Estradiol results in increased expression of CDK2AP1 mRNA CTD PMID:39298647 Cdk2ap1 Rat 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO CDK2AP1 (Homo sapiens) 6480464 Metribolone results in increased expression of CDK2AP1 mRNA CTD PMID:17010196 Cdk2ap1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cdk2ap1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CDK2AP1 mRNA CTD PMID:24680724 Cdk2ap1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDK2AP1 mRNA CTD PMID:34747641 Cdk2ap1 Rat 4,4'-diaminodiphenylmethane increases expression ISO Cdk2ap1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CDK2AP1 mRNA CTD PMID:18648102 Cdk2ap1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CDK2AP1 mRNA CTD PMID:30047161 Cdk2ap1 Rat aflatoxin B1 increases expression ISO CDK2AP1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CDK2AP1 mRNA CTD PMID:22100608 Cdk2ap1 Rat all-trans-retinoic acid decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CDK2AP1 mRNA CTD PMID:33167477 Cdk2ap1 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of CDK2AP1 mRNA CTD PMID:30047161 Cdk2ap1 Rat antirheumatic drug increases expression ISO CDK2AP1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of CDK2AP1 mRNA CTD PMID:24449571 Cdk2ap1 Rat arsenite(3-) multiple interactions ISO CDK2AP1 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to CDK2AP1 mRNA] CTD PMID:32406909 Cdk2ap1 Rat atrazine decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 Atrazine results in decreased expression of CDK2AP1 mRNA CTD PMID:22378314 Cdk2ap1 Rat benzo[a]pyrene affects methylation ISO CDK2AP1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CDK2AP1 promoter CTD PMID:27901495 Cdk2ap1 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of CDK2AP1 mRNA CTD PMID:33754040 Cdk2ap1 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDK2AP1 mRNA CTD PMID:25181051 Cdk2ap1 Rat bisphenol A decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 bisphenol A results in decreased expression of CDK2AP1 mRNA CTD PMID:35598803 Cdk2ap1 Rat bisphenol A multiple interactions ISO CDK2AP1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CDK2AP1 gene CTD PMID:31601247 Cdk2ap1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDK2AP1 mRNA CTD PMID:32145629 Cdk2ap1 Rat bisphenol A affects expression ISO CDK2AP1 (Homo sapiens) 6480464 bisphenol A affects the expression of CDK2AP1 mRNA CTD PMID:30903817 Cdk2ap1 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CDK2AP1 mRNA CTD PMID:19167457 Cdk2ap1 Rat carbon nanotube increases expression ISO Cdk2ap1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Cdk2ap1 Rat chromium(6+) affects expression ISO Cdk2ap1 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of CDK2AP1 mRNA CTD PMID:28472532 Cdk2ap1 Rat cisplatin increases expression ISO CDK2AP1 (Homo sapiens) 6480464 Cisplatin results in increased expression of CDK2AP1 mRNA CTD PMID:19561079 and PMID:27594783 Cdk2ap1 Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CDK2AP1 mRNA CTD PMID:24386269 Cdk2ap1 Rat cobalt dichloride decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CDK2AP1 mRNA CTD PMID:19320972 Cdk2ap1 Rat cyclosporin A decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CDK2AP1 mRNA CTD PMID:25562108 and PMID:27989131 Cdk2ap1 Rat cyclosporin A decreases methylation ISO CDK2AP1 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of CDK2AP1 promoter CTD PMID:27989131 Cdk2ap1 Rat dibutyl phthalate decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CDK2AP1 mRNA CTD PMID:17361019 and PMID:21266533 Cdk2ap1 Rat finasteride increases expression EXP 6480464 Finasteride results in increased expression of CDK2AP1 mRNA CTD PMID:24136188 Cdk2ap1 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of CDK2AP1 mRNA CTD PMID:24136188 Cdk2ap1 Rat folic acid decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 Folic Acid results in decreased expression of CDK2AP1 mRNA CTD PMID:25629700 Cdk2ap1 Rat folic acid multiple interactions ISO Cdk2ap1 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of CDK2AP1 mRNA] CTD PMID:22206623 Cdk2ap1 Rat fulvestrant multiple interactions ISO CDK2AP1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CDK2AP1 gene CTD PMID:31601247 Cdk2ap1 Rat glafenine increases expression EXP 6480464 Glafenine results in increased expression of CDK2AP1 mRNA CTD PMID:24136188 Cdk2ap1 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of CDK2AP1 mRNA CTD PMID:30047161 Cdk2ap1 Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CDK2AP1 mRNA CTD PMID:22546817 Cdk2ap1 Rat paracetamol affects expression ISO Cdk2ap1 (Mus musculus) 6480464 Acetaminophen affects the expression of CDK2AP1 mRNA CTD PMID:17562736 Cdk2ap1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDK2AP1 mRNA CTD PMID:33387578 Cdk2ap1 Rat pentachlorophenol increases expression ISO Cdk2ap1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CDK2AP1 mRNA CTD PMID:23892564 Cdk2ap1 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CDK2AP1 mRNA CTD PMID:30047161 Cdk2ap1 Rat PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of CDK2AP1 mRNA CTD PMID:15215175 Cdk2ap1 Rat pinosylvin decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 pinosylvin results in decreased expression of CDK2AP1 mRNA CTD PMID:23333577 Cdk2ap1 Rat pirinixic acid increases expression ISO Cdk2ap1 (Mus musculus) 6480464 pirinixic acid results in increased expression of CDK2AP1 mRNA CTD PMID:23811191 Cdk2ap1 Rat propiconazole increases expression ISO Cdk2ap1 (Mus musculus) 6480464 propiconazole results in increased expression of CDK2AP1 mRNA CTD PMID:21278054 Cdk2ap1 Rat sodium arsenite increases expression ISO CDK2AP1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CDK2AP1 mRNA CTD PMID:34032870 Cdk2ap1 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CDK2AP1 mRNA CTD PMID:30047161 Cdk2ap1 Rat temozolomide increases expression ISO CDK2AP1 (Homo sapiens) 6480464 Temozolomide results in increased expression of CDK2AP1 mRNA CTD PMID:31758290 Cdk2ap1 Rat titanium dioxide increases methylation ISO Cdk2ap1 (Mus musculus) 6480464 titanium dioxide results in increased methylation of CDK2AP1 gene CTD PMID:35295148 Cdk2ap1 Rat trans-pinosylvin decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 pinosylvin results in decreased expression of CDK2AP1 mRNA CTD PMID:23333577 Cdk2ap1 Rat Tributyltin oxide decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CDK2AP1 mRNA CTD PMID:18958704 Cdk2ap1 Rat trimellitic anhydride increases expression ISO Cdk2ap1 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CDK2AP1 mRNA CTD PMID:19042947 Cdk2ap1 Rat triptonide increases expression ISO Cdk2ap1 (Mus musculus) 6480464 triptonide results in increased expression of CDK2AP1 mRNA CTD PMID:33045310 Cdk2ap1 Rat tungsten increases expression ISO Cdk2ap1 (Mus musculus) 6480464 Tungsten results in increased expression of CDK2AP1 mRNA CTD PMID:30912803 Cdk2ap1 Rat valproic acid decreases expression ISO Cdk2ap1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of CDK2AP1 mRNA CTD PMID:20546886 and PMID:21427059 Cdk2ap1 Rat valproic acid affects expression ISO CDK2AP1 (Homo sapiens) 6480464 Valproic Acid affects the expression of CDK2AP1 mRNA CTD PMID:25979313 Cdk2ap1 Rat valproic acid increases methylation ISO CDK2AP1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CDK2AP1 gene CTD PMID:29154799 Cdk2ap1 Rat valproic acid decreases expression ISO CDK2AP1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CDK2AP1 mRNA CTD PMID:28001369 and PMID:29154799
1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP,ISO) 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 4,4'-diaminodiphenylmethane (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) antirheumatic drug (ISO) arsenite(3-) (ISO) atrazine (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) C60 fullerene (EXP) carbon nanotube (ISO) chromium(6+) (ISO) cisplatin (ISO) cobalt dichloride (EXP,ISO) cyclosporin A (ISO) dibutyl phthalate (ISO) finasteride (EXP) flutamide (EXP) folic acid (ISO) fulvestrant (ISO) glafenine (EXP) methimazole (EXP) nickel dichloride (EXP) paracetamol (EXP,ISO) pentachlorophenol (ISO) phenobarbital (EXP) PhIP (EXP) pinosylvin (ISO) pirinixic acid (ISO) propiconazole (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) temozolomide (ISO) titanium dioxide (ISO) trans-pinosylvin (ISO) Tributyltin oxide (ISO) trimellitic anhydride (ISO) triptonide (ISO) tungsten (ISO) valproic acid (ISO)
Cdk2ap1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 37,910,718 - 37,919,446 (+) NCBI GRCr8 mRatBN7.2 12 32,249,752 - 32,258,483 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 32,249,747 - 32,258,479 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 12 33,429,132 - 33,437,872 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 12 34,040,461 - 34,049,199 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 12 33,092,339 - 33,101,075 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 12 37,668,369 - 37,677,067 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 37,668,369 - 37,677,063 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 39,538,931 - 39,539,222 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 12 39,545,402 - 39,549,786 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 33,365,372 - 33,374,597 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 33,228,844 - 33,237,985 (+) NCBI Celera 12 33,942,086 - 33,946,470 (+) NCBI Celera Cytogenetic Map 12 q15 NCBI
CDK2AP1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 123,260,976 - 123,272,240 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 123,250,112 - 123,272,334 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 123,745,523 - 123,756,787 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 122,311,491 - 122,322,640 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 122,270,420 - 122,281,567 NCBI Celera 12 123,337,112 - 123,348,266 (-) NCBI Celera Cytogenetic Map 12 q24.31 NCBI HuRef 12 120,706,698 - 120,717,993 (-) NCBI HuRef CHM1_1 12 123,713,797 - 123,725,124 (-) NCBI CHM1_1 T2T-CHM13v2.0 12 123,257,499 - 123,268,761 (-) NCBI T2T-CHM13v2.0
Cdk2ap1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 124,483,502 - 124,492,691 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 124,483,480 - 124,501,145 (-) Ensembl GRCm39 Ensembl GRCm38 5 124,345,439 - 124,354,628 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 124,345,417 - 124,363,082 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 124,795,448 - 124,804,637 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 124,606,057 - 124,615,246 (-) NCBI MGSCv36 mm8 Celera 5 121,420,899 - 121,429,855 (-) NCBI Celera Cytogenetic Map 5 F NCBI cM Map 5 63.53 NCBI
Cdk2ap1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955482 5,588,674 - 5,593,896 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955482 5,588,683 - 5,593,896 (+) NCBI ChiLan1.0 ChiLan1.0
CDK2AP1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 131,348,690 - 131,359,527 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 131,345,066 - 131,355,880 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 120,859,240 - 120,870,443 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 125,092,593 - 125,103,452 (-) NCBI panpan1.1 PanPan1.1 panPan2
CDK2AP1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 26 6,283,071 - 6,293,595 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 17 52,363,464 - 52,363,811 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 26 6,284,535 - 6,293,591 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 26 6,445,257 - 6,455,733 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 26 6,532,579 - 6,543,449 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 26 6,532,966 - 6,543,449 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 26 6,466,330 - 6,476,809 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 26 6,558,200 - 6,568,672 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 26 6,511,768 - 6,522,244 (+) NCBI UU_Cfam_GSD_1.0
Cdk2ap1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
CDK2AP1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 29,631,084 - 29,642,253 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 29,631,084 - 29,642,262 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 31,321,811 - 31,332,455 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CDK2AP1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 118,602,354 - 118,613,006 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 118,603,089 - 118,612,971 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 126,696,959 - 126,708,401 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cdk2ap1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 82 Count of miRNA genes: 56 Interacting mature miRNAs: 73 Transcripts: ENSRNOT00000001419 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631560 Apr1 Acute phase response QTL 1 6.1 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 19144362 46669029 Rat 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 3.5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 8693635 Alc28 Alcohol consumption QTL 28 2.7 0.439 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 44726024 Rat 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 14 nervous system integrity trait (VT:0010566) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) 12 19610870 46669029 Rat 9590147 Scort7 Serum corticosterone level QTL 7 13.61 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 12 1 42110980 Rat 1549829 Scl48 Serum cholesterol level QTL 48 5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 12 9603277 46669029 Rat 737822 Alc10 Alcohol consumption QTL 10 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 19610870 40218516 Rat 2293684 Bmd26 Bone mineral density QTL 26 4.4 0.0002 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 12 15872653 32974238 Rat 70169 Eae13 Experimental allergic encephalomyelitis QTL 13 0.032 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 12 24139202 36638073 Rat 1600386 Calcic2 Intracellular calcium level QTL 2 0.001 platelet physiology trait (VT:0005464) platelet intracellular calcium level (CMO:0000922) 12 28064433 46669029 Rat 1302792 Scl21 Serum cholesterol level QTL 21 3.8 0.0011 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 12 7196730 46669029 Rat 1556747 Calcic1 Intracellular calcium level QTL 1 3.6 platelet calcium amount (VT:0010500) platelet intracellular calcium level (CMO:0000922) 12 28064433 40130419 Rat 631829 Alc6 Alcohol consumption QTL 6 4.7 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 28607526 37691617 Rat 8693658 Alc33 Alcohol consumption QTL 33 2.1 0.68 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 43551788 Rat 1598855 Bp294 Blood pressure QTL 294 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 1 34851688 Rat 1331761 Bp218 Blood pressure QTL 218 2.973 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 45055165 Rat 8694179 Bw150 Body weight QTL 150 2.9 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411545 Bw128 Body weight QTL 128 5.2 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411547 Bw129 Body weight QTL 129 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 5564495 46669029 Rat 737979 Pia22 Pristane induced arthritis QTL 22 53.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 1 44465750 Rat 1298081 Cia25 Collagen induced arthritis QTL 25 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610889 35682913 Rat 2300186 Bmd59 Bone mineral density QTL 59 7.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 12 10474137 46669029 Rat 7411660 Foco28 Food consumption QTL 28 10.9 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 3.72 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 19835789 38193007 Rat 7411641 Foco19 Food consumption QTL 19 27.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 7411643 Foco20 Food consumption QTL 20 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 20328819 46669029 Rat 5684888 Pia42 Pristane induced arthritis QTL 42 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610870 42828880 Rat 1549912 Bp268 Blood pressure QTL 268 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 13182736 46669029 Rat 2302060 Pia37 Pristane induced arthritis QTL 37 6.1 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 13198157 46669029 Rat 1641928 Alcrsp5 Alcohol response QTL 5 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 12 12812385 46669029 Rat 1300162 Bp188 Blood pressure QTL 188 3.19 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 32103174 45899022 Rat 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564498 46669029 Rat 10059594 Kidm46 Kidney mass QTL 46 3.79 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 12 6107579 46669029 Rat 9590086 Insglur6 Insulin/glucose ratio QTL 6 18.97 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 12 1 42110980 Rat 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 1549902 Bp269 Blood pressure QTL 269 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 13182736 46669029 Rat 61404 Bw120 Body weight QTL 120 5.1 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 12 12351619 46669029 Rat 1300175 Cm5 Cardiac mass QTL 5 3.78 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 12 28064433 45899022 Rat 1331787 Rf41 Renal function QTL 41 2.998 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 12 28064557 40218380 Rat 2293699 Bss49 Bone structure and strength QTL 49 5.61 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 12 10474137 46669029 Rat 634351 Apr5 Acute phase response QTL 5 6.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 12 1 44503507 Rat 634350 Apr4 Acute phase response QTL 4 6 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 1172005 46172005 Rat 7387292 Kidm42 Kidney mass QTL 42 3.03 0.0004 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 12 1 36247923 Rat 61421 Cia12 Collagen induced arthritis QTL 12 4.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 13635523 35682913 Rat 2303569 Gluco44 Glucose level QTL 44 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 12812385 46669029 Rat 7411586 Foco5 Food consumption QTL 5 5.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 2303575 Insul14 Insulin level QTL 14 4 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 12 1 42450532 Rat 7411588 Foco6 Food consumption QTL 6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2302042 Pia38 Pristane induced arthritis QTL 38 3.5 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 1 44503507 Rat 7411595 Foco9 Food consumption QTL 9 4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 7411597 Foco10 Food consumption QTL 10 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 631543 Bp83 Blood pressure QTL 83 5.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 15550826 38478808 Rat
RH127739
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 32,258,656 - 32,258,851 (+) MAPPER mRatBN7.2 Rnor_6.0 12 37,677,241 - 37,677,435 NCBI Rnor6.0 Rnor_5.0 12 39,549,962 - 39,550,156 UniSTS Rnor5.0 RGSC_v3.4 12 33,374,773 - 33,374,967 UniSTS RGSC3.4 Celera 12 33,946,646 - 33,946,840 UniSTS RH 3.4 Map 12 566.9 UniSTS Cytogenetic Map 12 q15 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000001419 ⟹ ENSRNOP00000001419
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 32,253,140 - 32,258,479 (+) Ensembl Rnor_6.0 Ensembl 12 37,668,369 - 37,677,063 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000100788 ⟹ ENSRNOP00000084668
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 32,254,789 - 32,258,479 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000107655 ⟹ ENSRNOP00000078090
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 32,249,747 - 32,258,474 (+) Ensembl
RefSeq Acc Id:
NM_001113751 ⟹ NP_001107223
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 37,910,718 - 37,919,446 (+) NCBI mRatBN7.2 12 32,249,752 - 32,258,483 (+) NCBI Rnor_6.0 12 37,668,369 - 37,677,065 (+) NCBI Rnor_5.0 12 39,538,931 - 39,539,222 (+) NCBI Rnor_5.0 12 39,545,402 - 39,549,786 (+) NCBI RGSC_v3.4 12 33,365,372 - 33,374,597 (+) RGD Celera 12 33,942,086 - 33,946,470 (+) RGD
Sequence:
CGCGCCCGATGTATGGGTGATATACTGCGGCGGCGGCAGGGTGAGGGACGGCCATATTTGCCGGCGCGGCCCGAGCCGGCGACAACAAAAAGTGCGCGGGCTCCCGGCAGGCGCTCGGACGGGTGCGG GGACGTGGGGCCGCCCGGCCCGGGCCTCGGCCTCGGCCTCGCCGCCGCCGCTGCGCTCGCGGCCTGGCCCGGCTCTGCCCGGCGCGCCCGCCGCCCGCGGGGATGTCGTACAAGCCGAACTTGACCGC GCACATGCCCGCCGCCGCCCTCAACGCCGGGAGTGTCCATTCACCGTCTACTAGCATGGCGACCTCCTCCCAGTATCGCCAGCTGCTGAGTGACTATGGGCCTCCATCGCTAGGCTACACCCAGGGAA CTGGAAATAGCCAGGTGCCTCAGAGTAAATATGCAGAGCTGCTGGCCATCATTGAAGAGTTGGGGAAAGAGATCAGACCCACGTATGCAGGGAGCAAGAGTGCCATGGAGAGGCTAAAACGAGGCATC ATTCATGCCCGAAGCCTGGTTCGGGAGTGCTTGGCTGAAACGGAACGGAACGCCAGGTCCTAGCCCCTGGCCAGTCTGCAGGCCCATCTCTACCCCATGGAGATGAGAGGCTTTGTTCAAAATGGCAG TAATTTTTCTACCACAGTCATTAAGCTCTGAACCCACACTCAAAAGATTGGGAAGACATTTTGCAGTAACTGACGATGTGCATTTTAAGTAGTTAGGAATGACCCAGCTCTTTTTTCTTTTCAAGCAT TTGAAAGATGTTTGTCAAGCCACTTCACAGCAAGCTATTGTTTGTCCCCAAATACCAGTGTCCCCTTTAACCTCCCTTTGGATACATTTTCCATTTGCATCACCCCAGTTGACTTCCTTTCCATGAGC TCACCTGCCTCTGAGGAGTTGAGTGCAGACCACAGCACGTTTGCTTAGTAGCTGGCCTGCCTGTGTACAGTGTAGACCCTGCTTCACGGAGCTTCTCTGCTTAAGCGTTTGCATGACTGAGTGCTTTG AAGTCAATCTTTAAAATGCACAGGTTATAAATACAGAAGAAAGAGCAATCCACCCAACCTACCAAGCACCCTGCAAATGTCCGTCCTGAGACTAGATCTCAGTTCCGTGTTTACTGTGAGCCGATCAC AACATCTGGAAGAAAACGACTGAAACGTTGCATCTTTGTATTTATTACTTGATGTAATAAAGCTTATTTTCATTAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_001401014 ⟹ NP_001387943
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 37,914,011 - 37,919,446 (+) NCBI mRatBN7.2 12 32,253,045 - 32,258,483 (+) NCBI
RefSeq Acc Id:
XM_008769239 ⟹ XP_008767461
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 37,911,835 - 37,919,444 (+) NCBI mRatBN7.2 12 32,250,880 - 32,258,483 (+) NCBI Rnor_6.0 12 37,670,537 - 37,677,067 (+) NCBI
Sequence:
CCCAGGCCCAGGCCGCTCTTTGTCTGGCGTGGGGGCGGGGAGCTGAGCCTGGCCCCAGGAGCTTCCTGGCCTCTGCCAAGCCCTCTCAGCTCTCTGCACACTGCGCTCATTGTCTGAGATGCTCCACA CCGGCTGAGCTGACGTGGAACCGCCTCCCTGGCCTCTTTCAGCCCAGGTGCTGGTGTCTTACAGAAGGAGAGGGCATGAGTGGCGGAGGAGCACCCTTCCACCCCGACTCCCCAGGGGGGCAGACATC TTCCTATTAATGAATAGGGTGCTGGCTTTGACACAAAGTCAGGTTCATCTCCACTCCTCCAGGGTGATACCAGGCTTGAGGTCCTCTGCCAGTATGGGGGTACTTCTCATTCCTTCTTTACCCTCAGC CCCTTAAGGGCATTCCCAACGTCATTAATCCTTCTACTGGGGAGCATGGCCTCAAACAAGTGGAGAAACTGAGCCCCGGAAGAGCCTTGACAGGTCCCACCGCCAGGAGTGGCACTGCTGGGACAGAC TCCCAAGTCCAGGAGAAAAGATGTGACAGGGAGGGAGTGTCCATTCACCGTCTACTAGCATGGCGACCTCCTCCCAGTATCGCCAGCTGCTGAGTGACTATGGGCCTCCATCGCTAGGCTACACCCAG GGAACTGGAAATAGCCAGGTGCCTCAGAGTAAATATGCAGAGCTGCTGGCCATCATTGAAGAGTTGGGGAAAGAGATCAGACCCACGTATGCAGGGAGCAAGAGTGCCATGGAGAGGCTAAAACGAGG CATCATTCATGCCCGAAGCCTGGTTCGGGAGTGCTTGGCTGAAACGGAACGGAACGCCAGGTCCTAGCCCCTGGCCAGTCTGCAGGCCCATCTCTACCCCATGGAGATGAGAGGCTTTGTTCAAAATG GCAGTAATTTTTCTACCACAGTCATTAAGCTCTGAACCCACACTCAAAAGATTGGGAAGACATTTTGCAGTAACTGACGATGTGCATTTTAAGTAGTTAGGAATGACCCAGCTCTTTTTTCTTTTCAA GCATTTGAAAGATGTTTGTCAAGCCACTTCACAGCAAGCTATTGTTTGTCCCCAAATACCAGTGTCCCCTTTAACCTCCCTTTGGATACATTTTCCATTTGCATCACCCCAGTTGACTTCCTTTCCAT GAGCTCACCTGCCTCTGAGGAGTTGAGTGCAGACCACAGCACGTTTGCTTAGTAGCTGGCCTGCCTGTGTACAGTGTAGACCCTGCTTCACGGAGCTTCTCTGCTTAAGCGTTTGCATGACTGAGTGC TTTGAAGTCAATCTTTAAAATGCACAGGTTATAAATACAGAAGAAAGAGCAATCCACCCAACCTACCAAGCACCCTGCAAATGTCCGTCCTGAGACTAGATCTCAGTTCCGTGTTTACTGTGAGCCGA TCACAACATCTGGAAGAAAACGACTGAAACGTTGCATCTTTGTATTTATTACTTGATGTAATAAAGCTTATTTTCATTAACA
hide sequence
RefSeq Acc Id:
XM_039089595 ⟹ XP_038945523
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 37,915,226 - 37,919,444 (+) NCBI mRatBN7.2 12 32,254,274 - 32,258,483 (+) NCBI
RefSeq Acc Id:
XM_063271533 ⟹ XP_063127603
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 37,911,569 - 37,919,444 (+) NCBI
RefSeq Acc Id:
NP_001107223 ⟸ NM_001113751
- Peptide Label:
isoform 1
- UniProtKB:
B0BN48 (UniProtKB/TrEMBL), F7F7G5 (UniProtKB/TrEMBL)
- Sequence:
MSYKPNLTAHMPAAALNAGSVHSPSTSMATSSQYRQLLSDYGPPSLGYTQGTGNSQVPQSKYAELLAIIEELGKEIRPTYAGSKSAMERLKRGIIHARSLVRECLAETERNARS
hide sequence
RefSeq Acc Id:
XP_008767461 ⟸ XM_008769239
- Peptide Label:
isoform X2
- Sequence:
MATSSQYRQLLSDYGPPSLGYTQGTGNSQVPQSKYAELLAIIEELGKEIRPTYAGSKSAMERLKRGIIHARSLVRECLAETERNARS
hide sequence
Ensembl Acc Id:
ENSRNOP00000001419 ⟸ ENSRNOT00000001419
RefSeq Acc Id:
XP_038945523 ⟸ XM_039089595
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6A030 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000084668 ⟸ ENSRNOT00000100788
Ensembl Acc Id:
ENSRNOP00000078090 ⟸ ENSRNOT00000107655
RefSeq Acc Id:
NP_001387943 ⟸ NM_001401014
- Peptide Label:
isoform 2
RefSeq Acc Id:
XP_063127603 ⟸ XM_063271533
- Peptide Label:
isoform X2
RGD ID: 13698615
Promoter ID: EPDNEW_R9139
Type: initiation region
Name: Cdk2ap1_1
Description: cyclin-dependent kinase 2 associated protein 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 12 37,668,328 - 37,668,388 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-05-24
Cdk2ap1
cyclin-dependent kinase 2 associated protein 1
LOC687549
similar to CDK2 (cyclin-dependent kinase 2)-associated protein 1
Data merged from RGD:1584216
1643240
APPROVED
2011-08-01
Cdk2ap1
cyclin-dependent kinase 2 associated protein 1
Cdk2ap1
CDK2-associated protein 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2010-02-04
Cdk2ap1
CDK2-associated protein 1
Cdk2ap1
cyclin-dependent kinase 2-associated protein 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-09-29
Cdk2ap1
cyclin-dependent kinase 2-associated protein 1
Cdk2ap1
CDK2 (cyclin-dependent kinase 2)-associated protein 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Cdk2ap1
CDK2 (cyclin-dependent kinase 2)-associated protein 1
Cdk2ap1_predicted
CDK2 (cyclin-dependent kinase 2)-associated protein 1 (predicted)
'predicted' is removed
2292626
APPROVED
2006-11-19
LOC687549
similar to CDK2 (cyclin-dependent kinase 2)-associated protein 1
Symbol and Name status set to provisional
70820
PROVISIONAL
2005-01-12
Cdk2ap1_predicted
CDK2 (cyclin-dependent kinase 2)-associated protein 1 (predicted)
Symbol and Name status set to approved
70820
APPROVED